Breast Cancer, Ductal Carcinoma In Situ , Inflammatory Breast Cancer , Invasive Ductal Carcinoma , Triple Negative Breast Cancer
Dr. Weinfurtner obtained his MD degree from Case Western Reserve University School of Medicine. He completed an internship at the University of Pennsylvania and a Radiology Residency at University Hospitals of Case Medical Center, where he served as Chief Resident. He most recently completed a Breast Imaging Fellowship at University of South Florida at Moffitt Cancer Center. Dr. Weinfurtner’s clinical interests involve multimodality diagnostic breast imagining. His research interest is in second opinion breast imaging and in breast cancer treatment response monitoring through imaging.
Education & Training
Moffitt Cancer Center - Breast Imaging
University Hospitals of Cleveland - Diagnostic Radiology
Case Western Reserve, University School of Medicine - MD
Weinfurtner RJ, Carter T. Transition to digital breast tomosynthesis-guided biopsies: Results and complications compared to stereotactic biopsies. Breast J. 2021 Jan.27(1):21-26. Pubmedid: 33302325.
Soliman H, Hogue D, Han HS, Mooney B, Lima Barros Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Rosa M, Khong H, Czerniecki BJ. A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast Cancer. Clin Cancer Res. 2021 Feb.27(4):1012-1018. Pubmedid: 33219014.
Funaro K, Prather A, Niell B, Jared Weinfurtner R. Tissue marker migration after MRI-guided breast biopsy: Migration frequency and associated factors. Breast J. 2020 Mar.26(3):440-445. Pubmedid: 31448455.
Weinfurtner RJ, Mooney B, Forbus J. Specialized Second Opinion Review of Breast MRI Impacts Management and Increases Cancer Detection. J Am Coll Radiol. 2019 Jul.16(7):922-927. Pubmedid: 30833163.
Fowler EEE, Hathaway C, Tillman F, Weinfurtner R, Sellers TA, Heine J. Spatial Correlation and Breast Cancer Risk. Biomed Phys Eng Express. 2019 Jul.5(4). Pubmedid: 33304615. Pmcid: PMC7725237.
Falcon S, Weinfurtner RJ, Mooney B, Niell BL. SAVI SCOUT® localization of breast lesions as a practical alternative to wires: Outcomes and suggestions for trouble-shooting. Clin Imaging. 2019 Jan.52:280-286. Pubmedid: 30193186.
Weinfurtner RJ, Niell B, Mekhail Y, Aguila E, Kamat L. Specialized Second Opinion Interpretations of Breast Imaging: Impact on Additional Workup and Management. Clin Breast Cancer. 2018 Oct.18(5):e1031-e1036. Pubmedid: 29625911.
Assing MA, Patel BK, Karamsadkar N, Weinfurtner J, Usmani O, Kiluk JV, Drukteinis JS. A comparison of the diagnostic accuracy of magnetic resonance imaging to axillary ultrasound in the detection of axillary nodal metastases in newly diagnosed breast cancer. Breast J. 2017 Nov.23(6):647-655. Pubmedid: 28397344.
Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS. Screening for Breast Cancer. Radiol Clin North Am. 2017 Nov.55(6):1145-1162. Pubmedid: 28991557.
Pribish AM, Saglam O, Weinfurtner RJ. Estrogen receptor-positive primary squamous cell carcinoma of the breast. Radiol Case Rep. 2017 Jun.12(2):211-214. Pubmedid: 28491153. Pmcid: PMC5417723.
Falcon S, Williams A, Weinfurtner J, Drukteinis JS. Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer. Cancer Control. 2017 Apr.24(2):125-136. Pubmedid: 28441367.
Kamat L, Rosa M, Weinfurtner R, Drukteinis J, Falcon S, Patel B. Primary Breast Angiosarcoma in a Male. Breast J. 2016 Jun.21(5):545-548. Pubmedid: 26183811.
Chaudhury B, Zhou M, Goldgof DB, Hall LO, Gatenby RA, Gillies RJ, Patel BK, Weinfurtner RJ, Drukteinis JS. Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis. J Magn Reson Imaging. 2015 Nov.42(5):1421-1430. Pubmedid: 25884277. Pmcid: PMC5017794.
Weinfurtner RJ, Patel B, Laronga C, Lee MC, Falcon SL, Mooney BP, Yue B, Drukteinis JS. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics. Clin Breast Cancer. 2015 Jun.15(3):234-239. Pubmedid: 25579460.
The Provider Rating is an average of all responses to specific care provider-related
questions from our nationally-recognized
Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our
Patient Satisfaction Survey . The comments are submitted by patients
and reflect their views and opinions. Patients are de-identified for confidentiality and
We post both positive and negative comments from the surveys. We do not post comments
that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may
risk the privacy of our patients.
A “[…]” in the comments below indicates de-identified patient information or comments that
are unrelated to the patient’s experience with the visit to the provider, such as
comments related to another provider, about the survey itself, or otherwise completely
Not all providers will have a star rating or comments. In order to ensure accuracy of our
ratings, we only display ratings for providers who have a minimum of 30 completed from
the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey
Patient Satisfaction Survey. If a provider does not have ratings or comments listed it
can be for several reasons, including:
The provider has not yet received the minimum number of patient satisfaction surveys
to be eligible for display. We require a minimum of 30 surveys before we post
results to ensure that the rating is statistically reliable and a true reflection of
He or she may be a researcher or other type of provider that does not see patients.
The provider practices in a specialty or office that does not use the specified
surveys currently used for these ratings.
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate buttonbelow. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub